Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Organon & Co. (NY: OGN ) 22.36 +1.47 (+7.04%) Official Closing Price Updated: 7:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,945,611 Open 21.00 Bid (Size) 21.64 (1) Ask (Size) 22.36 (66) Prev. Close 20.89 Today's Range 20.91 - 22.49 52wk Range 10.84 - 22.61 Shares Outstanding N/A Dividend Yield 5.01% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold August 20, 2024 On Tuesday, generic drug maker Organon stock had its Relative Strength (RS) Rating upgraded to 83, up from 78 a day earlier. Via Investor's Business Daily Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets August 20, 2024 From Organon & Co. Via Business Wire Performance YTD +52.01% +52.01% 1 Month +1.31% +1.31% 3 Month +6.58% +6.58% 6 Month +26.69% +26.69% 1 Year +2.29% +2.29% More News Read More OGN Stock Earnings: Organon Beats EPS, Misses Revenue for Q2 2024 August 06, 2024 Via InvestorPlace Organon Reports Results for the Second Quarter Ended June 30, 2024 August 06, 2024 From Organon & Co. Via Business Wire High Dividend 50: Organon & Co. June 27, 2024 Via Talk Markets Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount' July 30, 2024 Via Benzinga Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024 July 09, 2024 From Organon & Co. Via Business Wire 3 High-Yield Dividend ETFs to Buy to Generate Passive Income July 06, 2024 Via The Motley Fool Topics ETFs Value Investing Is Back! 3 Stocks With Strong Fundamentals to Buy Now June 26, 2024 Via InvestorPlace 3 Stocks With Mouthwatering Dividends You Can Buy Right Now June 08, 2024 Via The Motley Fool European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 May 24, 2024 From Organon & Co. Via Business Wire Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields May 10, 2024 Via Benzinga Organon Announces Pricing of $1.0 Billion Senior Notes Offering May 07, 2024 From Organon & Co. Via Business Wire Organon Announces Proposed $1.0 Billion Senior Notes Offering May 07, 2024 From Organon & Co. Via Business Wire Organon Beats On Q1, Women's Health Leads the Charge May 02, 2024 Via Benzinga OGN Stock Earnings: Organon Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 Via InvestorPlace Organon Reports Results for the First Quarter Ended March 31, 2024 May 02, 2024 From Organon & Co. Via Business Wire 7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024 May 01, 2024 Via InvestorPlace 3 Healthcare Stocks With the Potential to Triple Your Investment by 2026 May 01, 2024 Via InvestorPlace Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024 April 08, 2024 From Organon & Co. Via Business Wire Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints April 08, 2024 From Organon & Co. Via Business Wire Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields March 13, 2024 Via Benzinga Turn $500 into a Fortune: 3 Top Stock Picks for March’s Million-Dollar Rally March 07, 2024 Via InvestorPlace 5 Value Stocks In The Healthcare Sector March 04, 2024 Via Benzinga Drug Maker Organon Stock Scores Relative Strength Upgrade February 28, 2024 Via Investor's Business Daily Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.